lp-a.org

Testing

Lp(a) >50 mg/dL associates with multivessel disease and recurrent coronary events in the CERES cohort (Int J Cardiol 2026)

Original title: Lipoprotein(a) and an aggressive coronary disease phenotype: Association with multivessel disease and recurrent coronary events in the CERES study

Int J Cardiol · · 6

Gómez-Barrado JJ, Porras-Ramos Y, Camacho-Alcalá JA, Gómez-Turégano P, Gómez-Turégano M

This multicentre cohort study analysed 1833 patients with coronary artery disease from the CERES registry to assess whether elevated lipoprotein(a) identifies an aggressive coronary phenotype. After multivariable adjustment for age, sex, hypertension, diabetes, smoking, and historical maximum LDL cholesterol, continuous Lp(a) was independently associated with multivessel disease (OR 1.004; 95% CI 1.001-1.006) and recurrent coronary events (OR 1.004; 95% CI 1.001-1.006). Patients with Lp(a) >50 mg/dL had higher odds of multivessel disease (OR 1.406; 95% CI 1.144-1.730) and recurrent events (OR 1.504; 95% CI 1.166-1.942). The findings confirm Lp(a) as an independent marker of anatomical burden and clinical recurrence, though the observational design limits causal inference.

Read the paper (DOI)PubMed

Original abstract

Background: Lipoprotein(a) [Lp(a)] is an established genetically determined risk factor for atherosclerotic cardiovascular disease. Whether elevated Lp(a) identifies a broader phenotype of aggressive coronary disease, integrating anatomical disease burden and recurrent clinical manifestations, remains incompletely characterised.

Methods: We analysed 1892 patients with coronary artery disease from the multicentre CERES cohort after exclusion of myocardial infarction with non-obstructive coronary arteries (MINOCA). Lp(a) was analysed continuously, after natural-log transformation, and categorically using >50 mg/dL. Multivariable logistic regression models were adjusted for age, sex, hypertension, diabetes, smoking, and historical maximum LDL cholesterol (LDL-C).

Results: Lp(a) was available in 1833 patients; median concentration was 24.7 [9.1-63.7] mg/dL, and 33.2% had Lp(a) >50 mg/dL. Multivessel disease was present in 50.4% and recurrent coronary events in 19.5%. Lp(a) was independently associated with multivessel disease (OR, 1.004; 95% CI, 1.001-1.006; p = 0.002) and recurrent coronary events (OR, 1.004; 95% CI, 1.001-1.006; p = 0.003). Lp(a) >50 mg/dL was associated with multivessel disease (OR, 1.406; 95% CI, 1.144-1.730; p = 0.001) and recurrent events (OR, 1.504; 95% CI, 1.166-1.942; p = 0.002).

Conclusions: Elevated Lp(a) was independently associated with greater anatomical coronary disease burden and recurrent coronary events, supporting its role as a marker of an aggressive coronary disease phenotype.

epidemiologyrisktesting

Summary written by lp-a.org from the published abstract; figures as published. Page updated 6 November 2026. Methods.